Know Cancer

or
forgot password


Phase 3
18 Years
80 Years
Not Enrolling
Both
Myelodysplastic Syndromes

Thank you

Trial Information

Inclusion Criteria


- Eligible patients must have a diagnosis of myelodysplastic syndrome

- Life expectancy of at least 6 months.

- Patients must be able to adhere to the study visit schedule and other protocol
requirements.

- Patients must understand and voluntarily sign an informed consent document.

- Women of childbearing potential (WCBP) must agree to practice abstinence or to use
TWO methods of contraception beginning 4 weeks prior to the start of study medication
and throughout the course of treatment.

- Males must use barrier contraception when engaging in reproductive sexual activity
with women of childbearing potential.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

THAL-MDS-001

NCT ID:

NCT00050843

Start Date:

August 2001

Completion Date:

February 2004

Related Keywords:

  • Myelodysplastic Syndromes
  • Myelodysplastic Syndromes
  • Preleukemia

Name

Location

Roswell Park Cancer InstituteBuffalo, New York  14263
Mayo ClinicRochester, Minnesota  55905
University of Rochester Cancer CenterRochester, New York  14642
Whittingham Cancer CenterNorwalk, Connecticut  06856
Swedish Cancer InstituteSeattle, Washington  98104
Comprehensive Cancer Centers of the DesertPalm Springs, California  92262
Western Pennsylvania Cancer InstitutePittsburgh, Pennsylvania  15224
Florida Cancer SpecialistsFort Myers, Florida  33901
Southern Nevada Cancer Research FoundationLas Vegas, Nevada  89106
Oregon Health & Science UniversityPortland, Oregon  97201
Scripps Cancer CenterLa Jolla, California  92037
Central Utah Medical ClinicProvo, Utah  84604
Desert Hematology Oncology Medical Group INCRancho Mirage, California  92270
VA Connecticut Healthcare SystemWest Haven, Connecticut  06516
Southeast Florida Hematology-OncologyFt. Lauderdale, Florida  33308
Northwest Medical SpecialistsArlington Heights, Illinois  60004
Oncology AssociatesCedar Rapids, Iowa  52403
Beaumont Cancer CenterRoyal Oak, Michigan  48073
SMDC Health SystemsDuluth, Minnesota  55805
Jackson Oncology Associates PLLCJackson, Mississippi  39202
Hematology Oncology Consultants IncSt. Louis, Missouri  63136
Hematology Oncology Associates of NJParamus, New Jersey  07652
Summit Medical Group/Overlook Oncology CenterSummit, New Jersey  07901
Memorial Sloan Kettering Cancer CtrNew York, New York  10021
VAMC NorthportNorthport, New York  11768
South Shore Hem-Onc Assoc. PARockville Centre, New York  11570
Staten Island Unversity HospitalStaten Island, New York  10305
Westchester County Medical CenterValhalla, New York  10595
Buffalo Medical Group PCWilliamsville, New York  14221
Northwestern Carolina Hematology Oncology PAHickory, North Carolina  28602
Wake Forest Univ School of MedicineWinston Salem, North Carolina  27157-1082
Oncology/Hematology Care IncCincinnati, Ohio  45246
Medical Oncology AssociatesKingston, Pennsylvania  18704
Lancaster Cancer Center LTDLancaster, Pennsylvania  17605
MCP Hahnemann UniversityPhiladelphia, Pennsylvania  19129
Texas Oncology PA-BMT CenterDallas, Texas  75230
InterMountain Hematology/OncologySalt Lake City, Utah  84122
Yakima Regional CancerCenterYakima, Washington  98902